A role for cytomegalovirus-specific CD4 +CX3CR1 + T cells and cytomegalovirus-induced T-cell immunopathology in HIV-associated atherosclerosis

AIDS

Volumn 26, Issue 7, 2012, Pages 805-814

  Sacre, Karim ^a,b   Hunt, Peter W ^c   Hsue, Priscilla Y ^c   Maidji, Ekaterina ^a   Martin, Jeffrey N ^d   Deeks, Steven G ^c   Autran, Brigitte ^e   McCune, Joseph M ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b BICHAT HOSPITAL   (France)

^c SAN FRANCISCO GENERAL HOSPITAL   (United States)

^d UNIVERSITY OF CALIFORNIA   (United States)

^e PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

Author keywords

atherosclerosis; CD4 + T cells; CX3CL1; CX3CR1; cytomegalovirus; HIV

Indexed keywords

CHEMOKINE RECEPTOR CX3CR1;

ADULT; ARTERIAL WALL THICKNESS; ARTERY ENDOTHELIUM; ARTICLE; ATHEROSCLEROSIS; CD4+ T LYMPHOCYTE; CLINICAL ARTICLE; CONTROLLED STUDY; CORONARY ARTERY; CYTOKINE RELEASE; CYTOMEGALOVIRUS; CYTOMEGALOVIRUS INFECTION; DISEASE ASSOCIATION; DISEASE COURSE; FEMALE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNOPATHOGENESIS; MALE; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; T LYMPHOCYTE;

ADULT; ATHEROSCLEROSIS; CAROTID INTIMA-MEDIA THICKNESS; CASE-CONTROL STUDIES; CD4-POSITIVE T-LYMPHOCYTES; CHEMOKINE CX3CL1; CYTOMEGALOVIRUS; CYTOMEGALOVIRUS INFECTIONS; ENDOTHELIAL CELLS; FEMALE; HIV INFECTIONS; HUMANS; MALE; MIDDLE AGED; RECEPTORS, CHEMOKINE;

EID: 84862793506     PISSN: 02699370     EISSN: 14735571     Source Type: Journal    
DOI: 10.1097/QAD.0b013e328351f780     Document Type: Article

References (29)

1. Hsue PY, Lo JC, Franklin A, Bolger AF, Martin JN, Deeks SG, et al. Progression of atherosclerosis as assessed by carotid intima-media thickness in patients with HIV infection. Circulation 2004; 109:1603-1608. (Pubitemid 38451715)
2. Barbaro G, Fisher SD, Lipshultz SE. Pathogenesis of HIV-associated cardiovascular complications. Lancet Infect Dis 2001; 1:115-124. (Pubitemid 33586046)
3. Durand M, Sheehy O, Baril JG, Lelorier J, Tremblay CL. Association between HIV infection, antiretroviral therapy, and risk of acute myocardial infarction: a cohort and nested case-control study using Quebec's public health insurance database. J Acquir Immune Defic Syndr 2011; 57:245-253.
4. Baker JV, Henry WK, Patel P, Bush TJ, Conley LJ, Mack WJ, et al. Progression of carotid intima-media thickness in a contemporary human immunodeficiency virus cohort. Clin Infect Dis 2011; 53:826-835.
5. Van Vonderen MG, Hassink EA, van Agtmael MA, Stehouwer CD, Danner SA, Reiss P, et al. Increase in carotid artery intimamedia thickness and arterial stiffness but improvement in several markers of endothelial function after initiation of antiretroviral therapy. J Infect Dis 2009; 199:1186-1194.
6. Kaplan RC, Sinclair E, Landay AL, Lurain N, Sharrett AR, Gange SJ, et al. T cell activation and senescence predict subclinical carotid artery disease in HIV-infected women. J Infect Dis 2011; 203:452-463.
7. Hansson GK. Inflammation, atherosclerosis, and coronary artery disease. N Engl J Med 2005; 352:1685-1695.
8. Hsue PY, Hunt PW, Sinclair E, Bredt B, Franklin A, Killian M, et al. Increased carotid intima-media thickness in HIV patients is associated with increased cytomegalovirus-specific T-cell responses. AIDS 2006; 20:2275-2283. (Pubitemid 44789529)
9. Libby P. Inflammation in atherosclerosis. Nature 2002; 420: 868-874. (Pubitemid 36019640)
10. Valantine HA, Gao SZ, Menon SG, Renlund DG, Hunt SA, Oyer P, et al. Impact of prophylactic immediate posttransplant ganciclovir on development of transplant atherosclerosis: a post hoc analysis of a randomized, placebo-controlled study. Circulation 1999; 100:61-66. (Pubitemid 29297941)
11. Moatti D, Faure S, Fumeron F, Amara Mel W, Seknadji P, McDermott DH, et al. Polymorphism in the fractalkine receptor CX3CR1 as a genetic risk factor for coronary artery disease. Blood 2001; 97:1925-1928. (Pubitemid 32239068)
12. Bolovan-Fritts CA, Trout RN, Spector SA. Human cytomegalovirus-specific CD4R-T-cell cytokine response induces fractalkine in endothelial cells. J Virol 2004; 78:13173-13181. (Pubitemid 39517021)
13. Heiss G, Sharrett AR, Barnes R, Chambless LE, Szklo M, Alzola C. Carotid atherosclerosis measured by B-mode ultrasound in populations: associations with cardiovascular risk factors in the ARIC study. Am J Epidemiol 1991; 134:250-256.
14. Grazia Revello M, Baldanti F, Percivalle E, Sarasini A, De-Giuli L, Genini E, et al. In vitro selection of human cytomegalovirus variants unable to transfer virus and virus products from infected cells to polymorphonuclear leukocytes and to grow in endothelial cells. J Gen Virol 2001; 82:1429-1438. (Pubitemid 32519774)
15. O'Leary DH, Polak JF, Kronmal RA, Manolio TA, Burke GL, Wolfson SK Jr. Carotid-artery intima and media thickness as a risk factor for myocardial infarction and stroke in older adults. Cardiovascular Health Study Collaborative Research Group. N Engl J Med 1999; 340:14-22. (Pubitemid 29024679)
16. Hendriks J, Gravestein LA, Tesselaar K, van Lier RA, Schumacher TN, Borst J. CD27 is required for generation and long-term maintenance of T cell immunity. Nat Immunol 2000; 1:433-440.
17. Sallusto F, Lenig D, Forster R, Lipp M, Lanzavecchia A. Two subsets of memory T lymphocytes with distinct homing potentials and effector functions. Nature 1999; 401:708-712.
18. Liu Z, Cumberland WG, Hultin LE, Prince HE, Detels R, Giorgi JV. Elevated CD38 antigen expression on CD8R T cells is a stronger marker for the risk of chronic HIV disease progression to AIDS and death in the Multicenter AIDS Cohort Study than CD4R cell count, soluble immune activation markers, or combinations of HLA-DR and CD38 expression. J Acquir Immune Defic Syndr Hum Retrovirol 1997; 16:83-92.
19. Jackson JB, Erice A, Englund JA, Edson JR, Balfour HH Jr. Prevalence of cytomegalovirus antibody in hemophiliacs and homosexuals infected with human immunodeficiency virus type 1. Transfusion 1988; 28:187-189.
20. Drew WL. Cytomegalovirus infection in patients with AIDS. J Infect Dis 1988; 158:449-456.
21. SacreK,CarcelainG,CassouxN, FilletAM,CostagliolaD,Vittecoq D, et al. Repertoire, diversity, and differentiation of specific CD8Tcellsareassociatedwithimmuneprotectionagainsthuman cytomegalovirus disease. J ExpMed 2005; 201:1999-2010. (Pubitemid 41002935)
22. Hansson GK, Robertson AK, Soderberg-Naucler C. Inflammation and atherosclerosis. Annu Rev Pathol 2006; 1:297-329.
23. Bromley SK, Thomas SY, Luster AD. Chemokine receptor CCR7 guides T cell exit from peripheral tissues and entry into afferent lymphatics. Nat Immunol 2005; 6:895-901. (Pubitemid 43090444)
24. Gotsman I, Grabie N, Dacosta R, Sukhova G, Sharpe A, Lichtman AH. Proatherogenic immune responses are regulated by the PD-1/PD-L pathway in mice. J Clin Invest 2007; 117:2974-2982. (Pubitemid 47529627)
25. Appay V, Dunbar PR, Callan M, Klenerman P, Gillespie GM, Papagno L, et al. Memory CD8R T cells vary in differentiation phenotype in different persistent virus infections. Nat Med 2002; 8:379-385. (Pubitemid 34407033)
26. Papagno L, Spina CA, Marchant A, Salio M, Rufer N, Little S, et al. Immune activation and CD8R T-cell differentiation towards senescence in HIV-1 infection. PLoS Biol 2004; 2:E20.
27. Frostegard J, Ulfgren AK, Nyberg P, Hedin U, Swedenborg J, Andersson U, et al. Cytokine expression in advanced human atherosclerotic plaques: dominance of pro-inflammatory (Th1) and macrophage-stimulating cytokines. Atherosclerosis 1999; 145:33-43. (Pubitemid 29292698)
28. Hunt PW, Martin JN, Sinclair E, Epling L, Teague J, Jacobson MA, et al. Valganciclovir reduces T cell activation in HIVinfected individuals with incomplete CD4R T cell recovery on antiretroviral therapy. J Infect Dis 2011; 203:1474-1483.
29. Appay V, Fastenackels S, Katlama C, Ait-Mohand H, Schneider L, Guihot A, et al. Old age and anti-CMV immunity are associated with altered T cell reconstitution in HIV-1 infected patients. AIDS 2011; 25:1813-1822.